Bioidentical hormones vs standard HRT: what is the difference?

Short answer

• “Bioidentical” hormones are molecules that are chemically identical to hormones your body makes (for example 17β‑estradiol or micronized progesterone).
• “Standard” HRT usually refers to FDA‑approved hormone products used in conventional medicine; some of those are bioidentical (e.g., estradiol, micronized progesterone) while others are synthetic progestins (e.g., medroxyprogesterone acetate).
• The main practical differences are where the product is made (FDA‑approved manufacturer vs a compounding pharmacy), the evidence and regulation behind it, and how dose/formulation is delivered — not the “naturalness” or innate safety.

Key points — what the terms mean

• Bioidentical = same chemical structure as endogenous human hormone (examples: 17β‑estradiol, micronized progesterone).
• Non‑bioidentical/synthetic hormones = different molecules that act on hormone receptors (examples: medroxyprogesterone acetate, norethindrone).
• “Compounded bioidentical hormones” = custom mixes made by compounding pharmacies (often creams, troches, pellets) tailored by dose; these are not FDA‑approved as a finished product.
• “FDA‑approved” HRT = products that went through clinical testing for safety, purity, dose consistency and labeling.

Examples of specific products

• Common FDA‑approved, bioidentical products: Estrace (oral estradiol), Climara/Vivelle‑Dot (estradiol patches), Divigel or EstroGel (estradiol gels), Prometrium (micronized progesterone). These have standardized dosing and regulated manufacturing.
• Common synthetic progestin example: Provera (medroxyprogesterone acetate).
• Pellet therapy clinics/brands that use compounded pellets: BioTE, SottoPelle (note these are typically compounded and clinic‑driven; Testopel is an FDA‑approved testosterone pellet for men).
• Testosterone products (usually for men or off‑label use in women): AndroGel, Testim, Nebido (testosterone undecanoate) — generally not marketed specifically for menopausal women in the US.

Safety, evidence and regulation

• FDA‑approved products: standardized potency, labeled dosing, clinical trials, and post‑marketing surveillance.
• Compounded BHRT: may be useful when a patient has a true need for a custom dose or formulation, but compounded preparations are not subject to the same pre‑market testing. Studies have found variability in hormone concentrations between compounded batches.
• Claims that compounded BHRT is safer or better at preventing breast cancer, heart disease or dementia are not supported by reliable evidence. Major medical societies (ACOG, The Endocrine Society, NAMS, FDA) warn against overblown claims.
• Route matters: transdermal estradiol (patch/gel) appears to have lower risk of venous thromboembolism than some oral estrogens in studies. Micronized progesterone may have a more favorable risk profile than some synthetic progestins for certain outcomes, but individual risks vary.

Practical pros and cons

• FDA‑approved HRT: pros = known doses, proven manufacturing, clearer safety data; cons = fixed formulations/doses may not suit every patient.
• Compounded BHRT: pros = customized dosing/combination, alternative formulations for intolerance; cons = less regulatory oversight, variable dosing, fewer safety/efficacy data, and sometimes costly.
• Beware clinics that use saliva tests to dose hormones — salivary testing is not a proven method for guiding systemic HRT dosing.

How to choose

• Discuss symptoms, medical history (breast cancer risk, clotting history, cardiovascular disease, liver disease), and goals with a clinician.
• Prefer FDA‑approved bioidentical products when possible (e.g., estradiol patches/gels, Prometrium for progestogen needs) because of quality control and evidence.
• Consider transdermal estradiol and micronized progesterone for many people seeking menopause symptom relief with attention to minimizing certain risks — but individual contraindications exist.
• If a clinician recommends compounded therapy (pellets, creams), ask why the FDA‑approved options aren’t suitable, ask about evidence, and choose a reputable compounding pharmacy/clinic; know there are potential downsides.

Bottom line “Bioidentical” describes the chemical identity of a hormone, but that label alone doesn’t guarantee safety or superiority. Many FDA‑approved HRT products are bioidentical and are preferable for most people because they are standardized and well studied. Compounded BHRT may be appropriate in select cases but carries additional uncertainties; discuss risks, benefits and alternatives with your clinician.

If you’d like, tell me your age, symptoms, and any relevant medical history and I can outline typical HRT options that would be appropriate to discuss with your clinician.